Literature DB >> 20493842

Regulation of CD8+ T cell responses to infection with parasitic protozoa.

Kimberly A Jordan1, Christopher A Hunter.   

Abstract

There are over 10,000 species of parasitic protozoa, a subset of which can cause considerable disease in humans. Here we examine in detail the complex immune response generated during infection with a subset of these parasites: Trypanosoma cruzi, Leishmania sp., Toxoplasma gondii, and Plasmodium sp. While these particular species perhaps represent the most studied parasites in terms of understanding how T cells function during infection, it is clear that the lessons learned from this body of work are also relevant to the other protozoa known to induce a CD8(+) T cell response. This review will highlight some of the key studies that established that CD8(+) T cells play a major role in protective immunity to protozoa, the factors that promote the generation as well as maintenance of the CD8(+) T cell response during these infections, and draw attention to some of the gaps in our knowledge. Moreover, the development of new tools, including MHC-Class I tetramer reagents and the use of TCR transgenic mice or genetically modified parasites, has provided a better appreciation of how parasite specific CD8(+) T cell responses are initiated and new insights into their phenotypic plasticity. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493842      PMCID: PMC2934887          DOI: 10.1016/j.exppara.2010.05.008

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  165 in total

1.  Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.

Authors:  Ruobing Wang; Judith Epstein; Yupin Charoenvit; Fe Maria Baraceros; Nancy Rahardjo; Tanya Gay; Jo-Glenna Banania; Rana Chattopadhyay; Patricia de la Vega; Thomas L Richie; Nadia Tornieporth; Denise L Doolan; Kent E Kester; D Gray Heppner; Jon Norman; Daniel J Carucci; Joe D Cohen; Stephen L Hoffman
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

2.  Knowlesi malaria: newly emergent and of public health importance?

Authors:  Janet Cox-Singh; Balbir Singh
Journal:  Trends Parasitol       Date:  2008-08-03

3.  Cutting edge: CD4+ T cell-derived IL-2 is essential for help-dependent primary CD8+ T cell responses.

Authors:  Elizabeth B Wilson; Alexandra M Livingstone
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

4.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

5.  Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.

Authors:  L Zhang; R L Tarleton
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

6.  Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.

Authors:  Elizabeth H Nardin; Giane A Oliveira; J Mauricio Calvo-Calle; Kristiane Wetzel; Carolin Maier; Ashley J Birkett; Pramod Sarpotdar; Michael L Corado; George B Thornton; Annette Schmidt
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors:  Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

8.  Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production.

Authors:  L Zhang; R L Tarleton
Journal:  Eur J Immunol       Date:  1996-01       Impact factor: 5.532

9.  Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.

Authors:  S Khusmith; M Sedegah; S L Hoffman
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii.

Authors:  Beena John; Tajie H Harris; Elia D Tait; Emma H Wilson; Beth Gregg; Lai Guan Ng; Paulus Mrass; David S Roos; Florence Dzierszinski; Wolfgang Weninger; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2009-07-03       Impact factor: 6.823

View more
  39 in total

1.  Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Authors:  Luiz Felipe Domingues Passero; Ana Kely Carvalho; Maria Luiza A C Bordon; Alexis Bonfim-Melo; Marcos Hikari Toyama; Carlos Eduardo Pereira Corbett; Márcia Dalastra Laurenti
Journal:  Inflamm Res       Date:  2011-12-14       Impact factor: 4.575

2.  Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Authors:  Charles S Rosenberg; Weibo Zhang; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 3.  Innate immunity to Toxoplasma gondii infection.

Authors:  Felix Yarovinsky
Journal:  Nat Rev Immunol       Date:  2014-02       Impact factor: 53.106

4.  Autophagy is a cell death mechanism in Toxoplasma gondii.

Authors:  Debasish Ghosh; Julia L Walton; Paul D Roepe; Anthony P Sinai
Journal:  Cell Microbiol       Date:  2012-02-08       Impact factor: 3.715

5.  Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.

Authors:  Ernesto S Nakayasu; Tiago J P Sobreira; Rafael Torres; Luciane Ganiko; Paulo S L Oliveira; Alexandre F Marques; Igor C Almeida
Journal:  J Proteome Res       Date:  2011-12-08       Impact factor: 4.466

Review 6.  The CD8 T-cell road to immunotherapy of toxoplasmosis.

Authors:  Rajarshi Bhadra; Jason P Gigley; Imtiaz A Khan
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

Review 7.  CD8+ T cell immunity in an encephalitis model of Toxoplasma gondii infection.

Authors:  SuJin Hwang; Imtiaz A Khan
Journal:  Semin Immunopathol       Date:  2015-05-06       Impact factor: 9.623

8.  CD45RO+ T Cells and T Cell Activation in the Long-Lasting Immunity after Leishmania infantum Infection.

Authors:  João F Rodrigues-Neto; Gloria R Monteiro; Tatjana S L Keesen; Henio G Lacerda; Edgar M Carvalho; Selma M B Jeronimo
Journal:  Am J Trop Med Hyg       Date:  2017-12-21       Impact factor: 2.345

9.  Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.

Authors:  Nian-Zhang Zhang; Si-Yang Huang; Ying Xu; Jia Chen; Jin-Lei Wang; Wei-Peng Tian; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

10.  Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii.

Authors:  Sonaimuthu Parthasarathy; Mun Yik Fong; Kalyanasundaram Ramaswamy; Yee Ling Lau
Journal:  Am J Trop Med Hyg       Date:  2013-03-18       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.